Director Denice Torres filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of 5,000 shares of Seaport Therapeutics, Inc. common stock on November 3, 2026.
DarioHealth Corp. filed an 8-K press release on November 4, 2026, announcing the appointment of John R. Palumbo as Chairman of the Board of Directors, effective November 3, 2026, succeeding Yoav Shaked who will remain a director.
AllianceBernstein Holding L.P. announced on November 4, 2026 the launch of the AB Equity Premium Income ETF, trading under the ticker INK on the NASDAQ, as an actively managed exchange-traded fund combining broad U.S. equity exposure with a written covered call option overlay.
Cynthia Pussinen, Chief Executive Officer and Director of Estrella Immunopharma, Inc. (NASDAQ:ESLA), filed a Form 4 on November 4, 2026, disclosing the acquisition of a stock option to purchase 1,000,000 shares of common stock, granted on November 2, 2026.
Shoals Technologies Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing an Agreement and Plan of Merger with Array Technologies, Inc. dated November 4, 2026, along with updated share counts as of October 28, 2026.
Kyndryl Holdings, Inc. filed a Form 8-K current report on November 4, 2026, disclosing that the company issued a press release announcing its results of operations for the second fiscal quarter ended September 30, 2026.
Vishay Intertechnology, Inc. filed a Form 8-K on November 4, 2026, announcing its financial results for the fiscal quarter and nine fiscal months ended October 3, 2026, and providing computational guidance on diluted earnings per share estimates for the fourth fiscal quarter of 2026.
CDW Corporation filed a Form 8-K on November 4, 2026, disclosing its third quarter 2026 financial results and announcing a quarterly cash dividend of $0.680 per common share.
Criteo S.A. filed a Form 8-K on November 4, 2026, disclosing that it issued a press release and planned to hold a conference call regarding its financial results for the quarter ended September 30, 2026.
Rythm Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting nine-month net income of $20,573 thousand driven by a $26,798 thousand income tax benefit, alongside a third-quarter net loss …